Predicting treatable traits for long-acting bronchodilators in patients with stable COPD
J Kang, KT Kim, JH Lee, EK Kim, TH Kim… - … Journal of Chronic …, 2017 - Taylor & Francis
Purpose There is currently no measure to predict a treatability of long-acting β-2 agonist
(LABA) or long-acting muscarinic antagonist (LAMA) in patients with chronic obstructive …
(LABA) or long-acting muscarinic antagonist (LAMA) in patients with chronic obstructive …
Predicting treatable traits for long-acting bronchodilators in patients with stable COPD
J Kang, KT Kim, JH Lee, EK Kim, TH Kim, KH Yoo… - 2017 - pubmed.ncbi.nlm.nih.gov
Purpose There is currently no measure to predict a treatability of long-acting β-2 agonist
(LABA) or long-acting muscarinic antagonist (LAMA) in patients with chronic obstructive …
(LABA) or long-acting muscarinic antagonist (LAMA) in patients with chronic obstructive …
Predicting treatable traits for long-acting bronchodilators in patients with stable COPD
J Kang, KT Kim, JH Lee, EK Kim, TH Kim… - International Journal of …, 2017 - go.gale.com
Purpose: There is currently no measure to predict a treatability of long-acting [beta]-2 agonist
(LABA) or long-acting muscarinic antagonist (LAMA) in patients with chronic obstructive …
(LABA) or long-acting muscarinic antagonist (LAMA) in patients with chronic obstructive …
Predicting treatable traits for long-acting bronchodilators in patients with stable COPD
J Kang, KT Kim, JH Lee, EK Kim… - INTERNATIONAL …, 2017 - scholarworks.bwise.kr
Purpose: There is currently no measure to predict a treatability of long-acting beta-2 agonist
(LABA) or long-acting muscarinic antagonist (LAMA) in patients with chronic obstructive …
(LABA) or long-acting muscarinic antagonist (LAMA) in patients with chronic obstructive …
Predicting treatable traits for long-acting bronchodilators in patients with stable COPD.
J Kang, KT Kim, JH Lee, EK Kim, TH Kim… - … Journal of Chronic …, 2017 - europepmc.org
Purpose There is currently no measure to predict a treatability of long-acting β-2 agonist
(LABA) or long-acting muscarinic antagonist (LAMA) in patients with chronic obstructive …
(LABA) or long-acting muscarinic antagonist (LAMA) in patients with chronic obstructive …
Predicting treatable traits for long-acting bronchodilators in patients with stable COPD
J Kang, KT Kim, JH Lee, EK Kim… - … Journal of COPD, 2017 - snucm.elsevierpure.com
Purpose: There is currently no measure to predict a treatability of long-acting β-2 agonist
(LABA) or long-acting muscarinic antagonist (LAMA) in patients with chronic obstructive …
(LABA) or long-acting muscarinic antagonist (LAMA) in patients with chronic obstructive …
[HTML][HTML] Predicting treatable traits for long-acting bronchodilators in patients with stable COPD
J Kang, KT Kim, JH Lee, EK Kim, TH Kim… - … Journal of Chronic …, 2017 - ncbi.nlm.nih.gov
Purpose There is currently no measure to predict a treatability of long-acting β-2 agonist
(LABA) or long-acting muscarinic antagonist (LAMA) in patients with chronic obstructive …
(LABA) or long-acting muscarinic antagonist (LAMA) in patients with chronic obstructive …
Predicting treatable traits for long-acting bronchodilators in patients with stable COPD
J Kang, KT Kim, JH Lee, EK Kim… - INTERNATIONAL …, 2017 - repository.hanyang.ac.kr
Purpose: There is currently no measure to predict a treatability of long-acting beta-2 agonist
(LABA) or long-acting muscarinic antagonist (LAMA) in patients with chronic obstructive …
(LABA) or long-acting muscarinic antagonist (LAMA) in patients with chronic obstructive …
Predicting treatable traits for long-acting bronchodilators in patients with stable COPD
J Kang, KT Kim, JH Lee, EK Kim, TH Kim… - … Journal of Chronic …, 2017 - dovepress.com
Purpose: There is currently no measure to predict a treatability of long-acting β-2 agonist
(LABA) or long-acting muscarinic antagonist (LAMA) in patients with chronic obstructive …
(LABA) or long-acting muscarinic antagonist (LAMA) in patients with chronic obstructive …
Predicting treatable traits for long-acting bronchodilators in patients with stable COPD.
J Kang, KT Kim, JH Lee, EK Kim, TH Kim… - … Journal of Chronic …, 2017 - europepmc.org
Purpose There is currently no measure to predict a treatability of long-acting β-2 agonist
(LABA) or long-acting muscarinic antagonist (LAMA) in patients with chronic obstructive …
(LABA) or long-acting muscarinic antagonist (LAMA) in patients with chronic obstructive …